Sag Health Science Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 20-12-2024
- Paid Up Capital ₹ 0.11 M
as on 20-12-2024
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.05 M
as on 20-12-2024
- Revenue 11.41%
(FY 2022)
- Profit 132.79%
(FY 2022)
- Ebitda 57.45%
(FY 2022)
- Net Worth 30.30%
(FY 2022)
- Total Assets -3.74%
(FY 2022)
About Sag Health Science
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.11 M.
The company currently has active open charges totaling ₹7.05 M.
Meena Bagga, Jeish Bagga, Pranay Bagga, and One other member serve as directors at the Company.
- CIN/LLPIN
U24297DL2013PTC253139
- Company No.
253139
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 May 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sag Health Science Private Limited offer?
Sag Health Science Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Cardiovascular Drugs & Medication, Diabetes Medicine, Pain Relief Drugs & Pharmaceuticals, Aceclofenac.
Who are the key members and board of directors at Sag Health Science?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meena Bagga  | Director | 30-May-2013 | Current |
| Jeish Bagga | Director | 15-Sep-2018 | Current |
| Pranay Bagga | Director | 13-Mar-2023 | Current |
| Anil Bagga | Director | 30-May-2013 | Current |
Financial Performance of Sag Health Science.
Sag Health Science Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.41% increase. The company also saw a substantial improvement in profitability, with a 132.79% increase in profit. The company's net worth Soared by an impressive increase of 30.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sag Health Science?
In 2022, Sag Health Science had a promoter holding of 90.91% and a public holding of 9.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 17 Oct 2023 | ₹2.05 M | Open |
Hdfc Bank Limited Creation Date: 03 Feb 2016 | ₹5.00 M | Open |
How Many Employees Work at Sag Health Science?
Unlock and access historical data on people associated with Sag Health Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sag Health Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sag Health Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
